Medicine and Dentistry
Patient
100%
Prostate Cancer
85%
Therapeutic Procedure
47%
Diagnosis
33%
Combination Therapy
32%
Follow up
23%
Biopsy
21%
Inpatient
20%
Neoplasm
20%
Health Care Cost
19%
Bladder Cancer
19%
Malignant Neoplasm
18%
Lesion
18%
Diseases
16%
Prostatectomy
15%
Surgery
15%
High-Intensity Focused Ultrasound
14%
Prostate Specific Antigen
13%
Magnetic Resonance Imaging
13%
Man
11%
Male
11%
Analysis
10%
Cancer
9%
Metastatic Carcinoma
9%
Complication
9%
Cystectomy
9%
Echography
9%
Urothelial Cancer
9%
Clear Cell Renal Cell Carcinoma
9%
Chemotherapeutic Agent
9%
Drug
8%
Gleason Score
8%
Suppressor of Cytokine Signaling 3
8%
Assessment
7%
Urine Cytology
7%
Overactive Bladder
7%
Incidence
7%
Biological Marker
7%
Organ
7%
Erectile Dysfunction
7%
Prostate Hypertrophy
7%
microRNA
7%
Side Effect
7%
Bladder
7%
Imaging Technique
6%
Recurrent Disease
6%
Prostate
6%
Retroperitoneal Lymph Node Dissection
6%
Serum
6%
Transitional Cell Carcinoma
6%
Biochemistry, Genetics and Molecular Biology
Magnetic Resonance Imaging
12%
Cancer Cell
9%
Prostate-Specific Antigen
7%
Health
6%
Ultrasound
6%
Testosterone
5%
Functional Magnetic Resonance Imaging
5%
Slice Culture
5%
Estrogen Receptor
5%
Life
5%
Nested Gene
5%
Contrast
5%
MicroRNA
5%
